<DOC>
	<DOCNO>NCT02408484</DOCNO>
	<brief_summary>This study ass efficacy Octafibrin , fibrinogen concentrate on-demand treatment spontaneous traumatic bleeding episode paediatric patient le 12 year age.The plan study duration 5 year . The study consider complete minimum 6 subject ( i.e. , least 3 subject age 0 &lt; 6 year 3 subject age 6 &lt; 12 year ) least one document bleeding episode total minimum 2 surgical procedure perform . All patient undergo pharmacokinetic ( PK ) study screen . This duration 14 day , patient treat bleed episode plan surgical procedure occur .</brief_summary>
	<brief_title>Study Assess Efficacy , Safety Pharmacokinetic Octafibrin Paediatric Subjects With Fibrinogen Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Afibrinogenemia</mesh_term>
	<criteria>Aged &lt; 12 year ( start treatment ) . Documented diagnosis congenital fibrinogen deficiency , expect require ondemand treatment bleed surgical prophylaxis : Fibrinogen deficiency manifest afibrinogenaemia severe hypofibrinogenaemia . Historical plasma fibrinogen activity &lt; 50 mg/dL level limit detection local assay method . Expected acute bleeding episode ( spontaneous trauma ) planning undergo elective surgery . Informed consent sign subject 's legal guardian . 1 . Life expectancy &lt; 6 month . 2 . Bleeding disorder congenital fibrinogen deficiency , include dysfibrinogenaemia . 3 . Prophylactic treatment fibrinogen concentrate . 4 . Treatment : Any fibrinogen concentrate fibrinogencontaining blood product within 2 week prior start treatment PK phase , bleed episode , surgery . Any coagulationactive drug ( i.e. , nonsteroidal antiinflammatory drug , warfarin , coumarin derivative , platelet aggregation inhibitor ) within 1 week prior start PK phase treatment bleed episode surgery , plan expect medication time period Day 1 24 hour ( i.e. , 1 day ) last Octafibrin infusion . 5 . Presence history : Hypersensitivity study medication . Deep vein thrombosis pulmonary embolism within 1 year prior start treatment bleed episode surgery . Arterial thrombosis within 1 year prior start treatment bleed episode surgery Hypersensitivity human plasma protein . Oesophageal varicose bleeding . Endstage liver disease ( i.e. , ChildPugh score B C ) . 6 . Known positive HIV infection viral load &gt; 200 particles/Î¼L &gt; 400,000 copies/mL . 7 . Polytrauma 1 year prior start treatment bleed episode surgery . 8 . Diagnosis suspicion neutralize antifibrinogen inhibitor currently time past . 9 . Acute chronic medical condition may , opinion investigator , affect conduct study , include subject receive immunemodulating drug ( antiretroviral chemotherapy ) , alphainterferon , prednisone ( equivalent &gt; 10 mg/day ) , similar drug , study start . 10 . Treatment IMP another interventional clinical study currently past 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>